Related Experiment Video
Updated: Feb 26, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Expression profile of circular RNAs in human gastric cancer tissues
You-Sheng Huang1, Na Jie1, Ke-Jian Zou2
1Department of Pathology, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan 571101, P.R. China.
Abstract:
Circular RNAs (circRNAs) represent a newly identified class of non‑coding RNA molecules, which interfere with gene transcription by adsorbing microRNAs (miRNAs). CircRNAs serve important roles in disease development and have the potential to serve as a novel class of biomarkers for clinical diagnosis. However, the role of circRNAs in the occurrence and development of gastric cancer (GC) remains unclear. In the present study, the expression profiles of circRNAs were compared between GC and adjacent normal tissues using a circRNA microarray, following which quantitative polymerase chain reaction (qPCR) was used to confirm the results of the circRNA microarray. Compared with the adjacent, normal mucosal tissues, 16 circRNAs were upregulated and 84 circRNAs were downregulated in GC. A total of 10 circRNAs were selected for validation in three pairs of GC and adjacent noncancerous tissues. The qPCR results were consistent with the findings of the microarray‑based expression analysis. Of the circRNAs studied, only circRNA‑0026 (hsa_circ_0000026) exhibited significantly different expression in GC (2.8‑fold, P=0.001). Furthermore, online Database for Annotation, Visualization and Integrated Discovery annotation was used to predict circRNA‑targeted miRNA‑gene interactions. The analysis revealed that circRNA‑0026 may regulate RNA transcription, RNA metabolism, gene expression, gene silencing and other biological functions in GC. In conclusion, differential expression of circRNAs may be associated with GC tumorigenesis, and circRNA‑0026 is a promising biomarker for GC diagnosis and targeted therapy.
Insights
Circular RNAs (circRNAs) are new non-coding RNAs impacting gene transcription. This study found circRNA-0026 is significantly altered in gastric cancer (GC), suggesting its potential as a diagnostic biomarker.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Circular RNAs (circRNAs) are emerging non-coding RNA molecules with roles in disease.
- Their specific involvement in gastric cancer (GC) pathogenesis is not well understood.
- circRNAs can interact with microRNAs (miRNAs), influencing gene expression.
Purpose of the Study:
- To investigate the expression profiles of circRNAs in gastric cancer (GC) tissues.
- To identify potential circRNA biomarkers for GC diagnosis and targeted therapy.
- To explore the regulatory functions of differentially expressed circRNAs in GC.
Main Methods:
- circRNA microarray analysis to compare expression between GC and normal tissues.
- Quantitative polymerase chain reaction (qPCR) for validation of microarray findings.
- Bioinformatic analysis (DAVID) to predict miRNA-gene interactions and biological functions.
Main Results:
- A significant number of circRNAs were differentially expressed in GC tissues compared to adjacent normal tissues (16 upregulated, 84 downregulated).
- circRNA-0026 (hsa_circ_0000026) showed significantly higher expression in GC tissues (2.8-fold, P=0.001).
- Bioinformatic analysis suggested circRNA-0026 may regulate key biological processes in GC, including transcription and gene silencing.
Conclusions:
- Differential expression of circRNAs is associated with gastric cancer tumorigenesis.
- circRNA-0026 is a potential diagnostic biomarker for gastric cancer.
- circRNA-0026 may serve as a target for novel gastric cancer therapies.

